Masami Tsuchiya

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Topics

Advanced Cancer

Psychometric Properties

Top Venues

Cancer chemotherapy and pharmacology

Journal of clinical pharmacy and therapeutics

Future oncology (London, England)

International journal of clinical pharmacy

This page only lists publications with an associated author ORCID identifier.

Publications

Keisuke Ikegami, Shungo Imai, Osamu Yasumuro, Masami Tsuchiya, Naomi Henmi, Mariko Suzuki, Katsuhisa Hayashi, Chisato Miura, Haruna Abe, Hayato Kizaki, Ryohkan Funakoshi, Yasunori Sato, Satoko Hori
External Validation and Update of the Risk Prediction Model for Denosumab-Induced Hypocalcemia Developed From a Hospital-Based Administrative Database. JCO clinical cancer informatics 8 (2024)
Masami Tsuchiya, Daisuke Kikuchi, Shiro Hatakeyama, Yuichi Tasaka, Takeshi Uchikura, Ryohkan Funakoshi, Taku Obara
Trend analysis of pharmacist involvement in cancer care in Japan from 2015 to 2020: A nationwide survey study on hospital pharmacy practice. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Masami Tsuchiya, Taku Obara, Masafumi Kikuchi, Nariyasu Mano
The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database. Cancer chemotherapy and pharmacology 91 (6) (2023)
Masami Tsuchiya, Taku Obara, Masafumi Kikuchi, Nariyasu Mano
The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database. Cancer chemotherapy and pharmacology (2023)
Masami Tsuchiya, Taku Obara, Masafumi Kikuchi, Nariyasu Mano
The prevalence of end-of-life chemotherapy and targeted therapy in Japan, assessed using a health claims database. Cancer chemotherapy and pharmacology 91 (6) (2023)
Masami Tsuchiya, Taku Obara, Nariyasu Mano
Itraconazole Contaminated with Rilmazafone in Japan: A Retrospective Analysis Using the Japanese Adverse Drug Event Report Database. Drugs - real world outcomes 9 (3) (2022)
Masami Tsuchiya, Daisuke Kikuchi, Shiro Hatakeyama, Yuichi Tasaka, Takeshi Uchikura, Ryohkan Funakoshi, Taku Obara
Characteristics of hospitals that report adverse drug reactions: Results of a nationwide survey in Japan. Journal of clinical pharmacy and therapeutics 47 (8) (2022)
Masami Tsuchiya, Hideyuki Terazono, Yosuke Maki, Naoki Yoshikawa, Yosuke Kawahara, Keiko Nishimura, Keisuke Shinohara, Daisuke Ogawa, Riho Mori, Yoshihiro Iwamoto, Fumio Itagaki, Hiroyuki Masuko, Masahito Yonemura, Mayako Uchida
Evaluation of a web-based educational programme for pharmacists during the COVID-19 pandemic in Japan. Journal of clinical pharmacy and therapeutics 46 (6) (2021)
Kentaro Tajima, Masami Tsuchiya, Tomofumi Ishikawa, Taku Obara, Nariyasu Mano
Real-world anticancer medications for reproductive-age women with breast cancer by using a claims database in Japan. Future oncology (London, England) 17 (15) (2021)
Aoi Noda, Masami Tsuchiya, Takamasa Sakai, Taku Obara, Nariyasu Mano
Adverse Drug Reaction Reports Regarding Abnormal Behavior After Oseltamivir Use in Children as Reported by Consumers or Healthcare Professionals. Patient preference and adherence 15 (2021)
Masami Tsuchiya, Taku Obara, Makoto Miyazaki, Aoi Noda, Chizuko Takamura, Nariyasu Mano
The quality assessment of the Japanese Adverse Drug Event Report database using vigiGrade. International journal of clinical pharmacy 42 (2) (2020)
Masami Tsuchiya, Taku Obara, Takamasa Sakai, Kaori Nomura, Chizuko Takamura, Nariyasu Mano
Quality evaluation of the Japanese Adverse Drug Event Report database (JADER). Pharmacoepidemiology and drug safety 29 (2) (2019)
Masami Tsuchiya, Akihisa Esashi, Taku Obara, Kyoko Inooka, Nariyasu Mano, Chizuko Takamura
Effect of Educational Interventions on Adverse Drug Reaction Reporting in a Cancer Institute in Japan: A Questionnaire Study. Hospital pharmacy 54 (2) (2018)